Linaclotide is Used for treating chronic idiopathic constipation, irritable bowel syndrome with constipation in adults, and functional constipation in pediatric patients. It was first introduced by Abbvie Inc in its drug Linzess on Aug 30, 2012. 3 different companies have introduced drugs containing Linaclotide.

Linaclotide Patents

Given below is the list of patents protecting Linaclotide, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Linzess	US9708371	Treatments for gastrointestinal disorders	Aug 16, 2033	Abbvie
Linzess	US8748573	Formulations comprising linaclotide	Oct 30, 2031	Abbvie
Linzess	US8802628	Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration	Oct 30, 2031	Abbvie
Linzess	US10675325	Stable formulations of linaclotide	Aug 11, 2031	Abbvie
Linzess	US10702576	Stable formulations of linaclotide	Aug 11, 2031	Abbvie
Linzess	US8933030	Treatments for gastrointestinal disorders	Feb 17, 2031	Abbvie
Linzess	US7304036	Methods and compositions for the treatment of gastrointestinal disorders	Aug 30, 2026	Abbvie
Linzess	US7371727	Methods and compositions for the treatment of gastrointestinal disorders	Jan 28, 2024 (Expired)	Abbvie
Linzess	US7704947	Methods and compositions for the treatment of gastrointestinal disorders	Jan 28, 2024 (Expired)	Abbvie
Linzess	US7745409	Methods and compositions for the treatment of gastrointestinal disorders	Jan 28, 2024 (Expired)	Abbvie
Linzess	US8080526	Methods and compositions for the treatment of gastrointestinal disorders	Jan 28, 2024 (Expired)	Abbvie
Linzess	US8110553	Methods and compositions for the treatment of gastrointestinal disorders	Jan 28, 2024 (Expired)	Abbvie

Add above patents to watchlist

Linaclotide's Family Patents

Full family tree

Linaclotide Generic API Manufacturers

Several generic applications have been filed for Linaclotide. The first generic version for Linaclotide was by Mylan Pharmaceuticals Inc and was approved on Feb 9, 2021. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Feb 7, 2023.

Given below is the list of companies who have filed for Linaclotide generic, along with the locations of their manufacturing plants worldwide.